Scarica l'app Stockscreener
4.87
0.41%
0.02
Precedente Chiudi:
$4.85
Aprire:
$4.85
Volume 24 ore:
2.51M
Relative Volume:
1.47
Capitalizzazione di mercato:
$866.19M
Reddito:
-
Utile/perdita netta:
$-45.44M
Rapporto P/E:
-13.91
EPS:
-0.35
Flusso di cassa netto:
$-42.28M
1 W Prestazione:
+0.83%
1M Prestazione:
+18.78%
6M Prestazione:
+136.41%
1 anno Prestazione:
+252.90%
Intervallo 1D:
$4.81
$5.00
Intervallo di 1 settimana:
$4.77
$5.11
Portata 52W:
$1.33
$5.11
Compass Therapeutics Inc Stock (CMPX) Company Profile
Nome
Compass Therapeutics Inc
Settore
Industria
Telefono
617-500-8099
Indirizzo
80 GUEST STREET, BOSTON
Confronta CMPX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CMPX
Compass Therapeutics Inc
|
4.87 | 862.63M | 0 | -45.44M | -42.28M | -0.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Compass Therapeutics Inc Stock (CMPX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-01 | Ripresa | Raymond James | Outperform |
| 2025-04-02 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2025-02-24 | Iniziato | Guggenheim | Buy |
| 2025-02-19 | Iniziato | Piper Sandler | Overweight |
| 2024-12-23 | Iniziato | D. Boral Capital | Buy |
| 2024-11-15 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-09-16 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2023-01-31 | Iniziato | Jefferies | Buy |
| 2023-01-27 | Iniziato | Stifel | Buy |
| 2022-05-23 | Ripresa | H.C. Wainwright | Buy |
| 2022-03-15 | Iniziato | Ladenburg Thalmann | Buy |
| 2022-01-19 | Iniziato | B. Riley Securities | Buy |
| 2021-12-22 | Iniziato | Raymond James | Outperform |
| 2021-12-20 | Iniziato | SVB Leerink | Outperform |
| 2021-12-15 | Iniziato | Wedbush | Outperform |
Mostra tutto
Compass Therapeutics Inc Borsa (CMPX) Ultime notizie
Will Compass Therapeutics Inc. stock outperform value stocksMarket Growth Review & Verified Technical Trade Signals - newser.com
How Compass Therapeutics Inc. stock performs in weak economy2025 Growth vs Value & Reliable Breakout Forecasts - newser.com
Why Compass Therapeutics Inc. stock is rated strong buyStop Loss & Stepwise Trade Signal Implementation - newser.com
Can Compass Therapeutics Inc. recover in the next quarterJuly 2025 Spike Watch & Low Risk Profit Maximizing Plans - newser.com
Is Compass Therapeutics Inc. stock recession proof2025 Earnings Impact & Short-Term High Return Ideas - newser.com
Compass Therapeutics Inc (CMPX) Performance and Fundamentals Dashboard tells a completely different story - Setenews
CEO Schuetz Surrenders 44,025 Of Compass Therapeutics Inc [CMPX] - TradingView
Compass Therapeutics Inc. (CMPX) is A Buy on Wall Street on Robust Pipeline Development - Insider Monkey
What analysts say about Compass Therapeutics Inc stockDebt-to-Equity Ratio Analysis & Low Risk Capital Growth - earlytimes.in
Why Compass Therapeutics Inc. stock is seen as undervaluedQuarterly Trade Review & Safe Entry Point Identification - newser.com
Compass Therapeutics stock hits 52-week high at $2.68 - MSN
Will Compass Therapeutics Inc. stock split attract more investorsCEO Change & Stock Market Timing Techniques - newser.com
How Compass Therapeutics Inc. stock trades before earningsMarket Growth Review & Free AI Powered Buy and Sell Recommendations - newser.com
Piper Sandler Initiates Coverage of Compass Therapeutics (CMPX) with Overweight Recommendation - MSN
Compass Therapeutics, Inc. (NASDAQ:CMPX) Given Average Rating of “Moderate Buy” by Analysts - Defense World
HC Wainwright Has Bullish Estimate for CMPX FY2025 Earnings - Defense World
What is Compass Therapeutics Inc (CMPX) Stock Return on Shareholders’ Capital? - Setenews
Compass Therapeutics Inc Azioni (CMPX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.38%
1.42%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):